Medical weight loss in Miami Beach that starts with your labs, not a script. At our South of Fifth office you meet Kelly Wolfe in person — a University of Miami-trained nurse practitioner with graduate research in leptin and appetite regulation — who builds your GLP-1 program around the metabolic reasons your weight is actually resistant.
Come in to 1000 5th Street in South Beach for a full metabolic workup, in-person injection teaching, and on-site InBody scans — then choose branded or compounded semaglutide and tirzepatide together. We see patients from across South Beach, Mid-Beach, Brickell, Coral Gables, and Bal Harbour. Prefer to stay home? Ask about our statewide telehealth program.
5.0
54 Google reviews
OWNER · UNIVERSITY OF MIAMI-TRAINED · FL APRN #11005134
1000 5th Street, Suite 414, Miami Beach, FL 33139 — South of Fifth (SoFi). Free street parking nearby; $4/hr attached garage.
Face-to-face consults, injection teaching, and on-site InBody body-composition scans — no rotating providers.
FDA-approved branded semaglutide (Wegovy®, Ozempic®) and tirzepatide (Zepbound®, Mounjaro®), or compounded equivalents from licensed pharmacies.
Comprehensive metabolic and hormone panel at baseline; repeat at 3–6 months to keep the medication working.
Baseline labs, then a customized 3-month starter, then $400/month refills with weekly check-ins. Confirmed in writing at consultation.
Every visit personally led by Kelly Wolfe, MSN, APRN, FNP-BC — owner, board-certified NP, and metabolism researcher.
Medical weight loss in Miami Beach is a medically supervised program that treats the biology behind weight gain — hormones, metabolism, and appetite regulation — rather than handing you a diet and a number to hit. It pairs FDA-approved GLP-1 medication with real lab work and ongoing provider oversight.
The difference between medical weight loss and a commercial diet program is the medicine and the monitoring. A GLP-1 receptor agonist like semaglutide, or a dual GLP-1/GIP agonist like tirzepatide, changes how your gut and brain regulate hunger — but the medication only does its job when the underlying metabolic picture is understood and corrected. That is the part most Miami clinics skip, and the part we build the entire program around.
Because the parts that actually determine your result — reading your labs, teaching you to inject correctly, measuring lean mass, and adjusting the dose to your body — are done better face to face.
A telehealth pill mill can ship you a pen in 48 hours. What it cannot do is sit across from you, walk through why your thyroid or insulin numbers are stalling the scale, demonstrate injection technique so you are confident from day one, and put you on an InBody scanner to prove you are losing fat rather than muscle. At our Miami Beach office, every one of those steps happens in the room with Kelly. You are not a chart in a queue — you are a patient she knows by name.
If in-person care isn’t practical for you, the same lab-driven protocol is available through our statewide telehealth program. The medicine is identical; the difference is whether the hands-on parts happen in our office or over secure video.
GLP-1 medical weight loss is FDA-approved for adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition — type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, or fatty liver disease.
Some patients are not candidates: a personal or family history of medullary thyroid carcinoma or MEN-2 syndrome, severe gastroparesis, active pancreatitis, pregnancy or breastfeeding, and active eating disorders are all exclusions. This is exactly why an in-person history and baseline labs come first — Kelly personally reviews every health history before a single prescription is written.
We prescribe both GLP-1 medications and choose between them based on your history, tolerance, and goals — not a default applied to everyone.
Tirzepatide produces greater average weight loss in head-to-head data — roughly 21% of total body weight versus roughly 15% for semaglutide — because it works on two appetite pathways instead of one. Semaglutide has a longer real-world safety record and often costs less. Each medication gets a dedicated deep-dive: read our full guides to semaglutide weight loss in Florida and tirzepatide weight loss in Florida, then we’ll decide together at your Miami Beach visit.
Branded or compounded is your call, made with full information. We offer FDA-approved Wegovy®, Ozempic®, Zepbound®, and Mounjaro®, as well as compounded semaglutide and tirzepatide from licensed pharmacies — with a clear explanation of the differences before you decide.
Every patient gets a comprehensive metabolic and hormone panel at baseline. The medication is the tool; the labs explain why your weight was resistant in the first place — and what else has to be addressed for the medication to deliver durable results.
This is the single biggest difference between us and most weight-loss clinics in Miami. Untreated hypothyroidism, undiagnosed insulin resistance, low testosterone, a perimenopausal estrogen drop, leptin resistance, cortisol dysregulation, and vitamin D deficiency all blunt GLP-1 response. When the labs point upstream, we often pair your program with bioidentical hormone optimization or targeted peptide therapy — not as upsells, but because correcting the driver is what lets the GLP-1 work at a lower dose.
Your first visit runs 60 to 75 minutes at our South of Fifth office. Kelly personally reviews your full history, orders your baseline panel, and — once labs are back, typically within 7 to 14 days — you leave your follow-up with a prescription and hands-on injection teaching.
The office is at 1000 5th Street, Suite 414, Miami Beach, FL 33139, at the southern tip of South Beach. There is a parking garage attached to the building at $4 per hour, and free street parking around the building during business hours (one nearby area is pay-to-park). It’s an easy drive from Mid-Beach, Brickell, Downtown, Coral Gables, and Bal Harbour.
The program begins with required baseline labs and a customized 3-month starter plan. After the starter, compounded semaglutide or tirzepatide refills are $400/month and include weekly check-ins and dose adjustments. Branded options are available; exact pricing is confirmed in writing at consultation.
Labs are required before any GLP-1 prescription can be written — they’re what make the program medical rather than a vending machine for injectables. We confirm your exact starter-program cost in writing at the consultation, so there are no surprises.
In pivotal trials, semaglutide averaged about 15% total body weight loss and tirzepatide about 21%, when paired with nutrition and training. Keeping the weight off is a program, not an accident.
Without a maintenance plan, regain after stopping GLP-1 medication is the published norm. With a structured taper, on-site InBody monitoring, and a protein-and-resistance-training protocol, the picture is different — and that ongoing, in-person accountability is exactly what the Miami Beach office is built to provide.
South Florida Face and Body sits in Suite 414 at 1000 5th Street, in the South of Fifth district of Miami Beach. From there, Kelly serves medical weight loss patients across Miami Beach, the barrier islands, and Miami proper.
Kelly’s office sits at the southern tip of Miami Beach — reachable from Brickell in under 10 minutes via the MacArthur Causeway, and a short hop up Collins from Mid-Beach, Surfside, and Bal Harbour. A $4/hour garage is attached to the building, with free street parking nearby during business hours (one nearby area is pay-to-park).
1000 5th Street, Suite 414 · Miami Beach, FL 33139
The geography matters because medical weight loss isn’t a one-and-done visit — it’s a relationship measured in months. You come in for baseline labs, return to review them, learn to inject, and check in as the dose titrates. A South of Fifth or Brickell patient who reaches us in minutes finds that monthly cadence effortless; a Bal Harbour or Sunny Isles patient may plan visits around the drive down Collins. We build your follow-up schedule around where you actually live — and for anyone outside an easy radius, the same lab-driven protocol is available through our statewide telehealth program.
Same-week consultations available. South of Fifth, Miami Beach.
Kelly is the owner of South Florida Face and Body. A board-certified Family Nurse Practitioner trained at the University of Miami, she holds advanced degrees in nursing, biochemistry, and biology, with graduate research focused on metabolism and the role of leptin and appetite-suppressing hormones. She practices at the intersection of functional medicine and aesthetic injection — meaning the conversations in her treatment room often go beyond the syringe to consider sleep, hormones, metabolism, and inflammation as part of how your skin and face actually present.
Licensed as an Advanced Practice Registered Nurse in the State of Florida (APRN #11005134), Kelly brings more than three decades of experience in health, fitness, and clinical practice. She has performed aesthetic injections in South Florida for over a decade and has trained alongside the dermatology and plastic surgery community that built Miami’s aesthetic reputation.
She is the one who answers your text message. She is the one who calls the day after your injection.
From your first consultation through every follow-up, you’ll work directly with Kelly — one injector, one set of hands, one consistent plan.
Advanced practice registered nursing with a focus on family health and primary care.
Research focused on metabolism and the role of leptin and appetite-suppressing hormones.
Research with a strong foundation in human physiology, cellular biology, and biochemistry.
National certification in family practice and primary care.
Authorized to diagnose, treat, and prescribe medications in the State of Florida.
Advanced training in root-cause diagnostics, hormone optimization, metabolic health, and integrative wellness.
Over 30 years helping clients achieve sustainable health and wellness transformations.
"Kelly is amazing! She's incredibly knowledgeable and progressive when it comes to facial aesthetics. My Botox and filler results are natural, refreshed, and exactly what I was hoping for — never overdone."
"Kelly is the best! She truly listens to what her clients want and delivers exactly what you picture. My results are always natural and beautiful. I couldn't recommend her more!"
"I was on holiday in Miami and got the details for Kelly. Best Botox I have had. She advised my husband who had very sore facial skin with a new routine and has cleared up the problem. Would certainly recommend."
The questions Miami Beach patients ask most before starting medical weight loss in person. If yours isn't here, Kelly is happy to answer directly — text or call.
Our office is at 1000 5th Street, Suite 414, Miami Beach, FL 33139, in the South of Fifth (SoFi) neighborhood at the southern tip of Miami Beach. Patients drive in from across South Beach, Mid-Beach, North Beach, Bal Harbour, Surfside, Brickell, Downtown Miami, and Coral Gables for in-person medical weight loss care. You can reach us at (786) 529-1860.
Yes. There is a parking garage attached to the building at $4 per hour. Street parking around the building is free during business hours, with the exception of one pay-to-park area nearby. We will point you to the closest free spaces when you book your first visit.
Both are available. This page covers our in-person medical weight loss program at the Miami Beach office, where you meet Kelly face to face, have labs reviewed in person, and get hands-on injection teaching. If you are elsewhere in Florida or prefer remote care, our statewide telehealth program delivers the same lab-driven protocol online.
The program begins with required baseline labs and a customized 3-month starter plan tailored to your labs, starting BMI, and clinical picture. After the starter program, compounded semaglutide or tirzepatide refills are $400 per month and include weekly check-ins and dose adjustments. Branded FDA-approved options are also available; exact pricing is confirmed in writing at your consultation.
Medical weight loss with GLP-1 therapy is FDA-approved for adults with a body mass index of 30 or higher, or 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, sleep apnea, or fatty liver disease. Patients with a personal or family history of medullary thyroid carcinoma, MEN-2 syndrome, severe gastroparesis, or active pancreatitis are not candidates. Kelly personally reviews every health history before prescribing.
Tirzepatide produces greater average weight loss in head-to-head trial data — about 21% of total body weight at 72 weeks versus about 15% at 68 weeks for semaglutide. Tirzepatide is a dual GLP-1 and GIP agonist; semaglutide is a single-pathway GLP-1 agonist with a longer real-world track record and often a lower cost. The right choice depends on your history, tolerance, and budget, and is decided with Kelly at your visit.
From our South of Fifth office we treat in-person medical weight loss patients from across Miami Beach, South Beach, Mid-Beach, North Beach, Bal Harbour, Surfside, Brickell, Downtown Miami, and Coral Gables. Same-week, in-person consultations are typically available.
The most common side effects of semaglutide and tirzepatide are gastrointestinal: nausea, decreased appetite, constipation, diarrhea, and occasional reflux. These are typically dose-dependent, peak in the first one to two weeks after each dose escalation, and resolve as the body adapts.
Less common but more serious side effects include pancreatitis, gallbladder disease, severe gastroparesis, and acute kidney injury from dehydration. Both medications carry a boxed warning for thyroid C-cell tumors observed in rodent studies; patients with a personal or family history of medullary thyroid carcinoma or MEN-2 should not take these medications.
Patients on anticoagulant or antiplatelet medication (aspirin, warfarin, Plavix, Eliquis, Xarelto) should disclose all current medications during your consultation. Do not discontinue any anticoagulant on your own — always consult your prescribing physician before making any changes to these medications.
Trademark notice. Wegovy®, Ozempic®, and Rybelsus® are registered trademarks of Novo Nordisk A/S. Zepbound®, Mounjaro®, and LillyDirect® are registered trademarks of Eli Lilly and Company. InBody® is a registered trademark of InBody Co., Ltd. Eliquis® is a registered trademark of Bristol-Myers Squibb Pharma Company. Xarelto® is a registered trademark of Bayer Aktiengesellschaft. Plavix® is a registered trademark of Sanofi-Aventis. Pradaxa® is a registered trademark of Boehringer Ingelheim. All other trademarks referenced are the property of their respective owners.
No affiliation. South Florida Face and Body is not affiliated with, endorsed by, sponsored by, or otherwise associated with Novo Nordisk A/S, Eli Lilly and Company, InBody Co., Ltd., or any other manufacturer of the medications or products referenced on this page. Use of these trademarks is solely for accurate identification of FDA-approved medications and for the educational benefit of our patients. References to brand-name medications do not imply that we dispense, distribute, or recommend any specific manufacturer’s product over compounded alternatives. Treatment decisions, including the choice between branded and compounded semaglutide or tirzepatide, are made between the patient and Kelly Wolfe, MSN, APRN, FNP-BC, based on individual clinical factors.
Medical disclaimer. The content on this page is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Clinical statistics cited (including STEP-1, SURMOUNT-1, SURMOUNT-4, and SURMOUNT-5 trial data) reflect published clinical trial averages and do not guarantee individual results. GLP-1 receptor agonists are prescription medications that require medical evaluation, ongoing supervision, and are not appropriate for every patient. Always consult a qualified healthcare provider before starting, stopping, or changing any medication — including semaglutide, tirzepatide, and any anticoagulant or other prescription drug you may currently take. If you experience a medical emergency, call 911.
Compounded medications notice. Compounded semaglutide and tirzepatide are prepared by state-licensed 503A or FDA-registered 503B pharmacies and are not the same product as FDA-approved Wegovy®, Ozempic®, Zepbound®, or Mounjaro®. Compounded medications are not reviewed by the FDA for safety, efficacy, or quality prior to dispensing. The FDA has not approved compounded semaglutide or compounded tirzepatide. Patients in our Florida program receive a clear explanation of the differences between branded and compounded formulations at consultation and choose accordingly.
